Prediction: Lilly Will Trade at Record High in 12 Months
Eli Lilly stock is surging on fresh obesity-drug data, fueling bets that the name could push toward a record high wit...
Determine whether a 6-month or 12-month fund is right for you by assessing income stability, essential expenses, and personal risk appetite.
15,911 articlesEli Lilly stock is surging on fresh obesity-drug data, fueling bets that the name could push toward a record high wit...
Pump.fun activity cratered over three months, pulling the PUMP token lower as traders pivot to Solana perpetual futur...
Ethereum clawed back from a dip toward $1.5K, but the longer-term trend remains bearish even as buyers defend a criti...
June data show a slower payroll rise and a drop in participation, fueling debate over the Fed’s 2026 path. The result...
Looking for breakout growth stocks hold potential for the next decade? This article breaks down three durable picks, ...
Crypto social activity just fell to a multi-month low, signaling a rare lull in online chatter. Analysts say this qui...
Energy stocks surged this month on higher oil prices driven by regional tensions, but market observers say valuations...
A sweeping wave of public and private spending is reshaping where people live and work. This is the largest infrastru...
Investor confidence is up—what’s making headlines? This article breaks down the forces behind a sunnier mood, what it...
Geopolitical conflicts are upending the classic playbook for U.S. stocks. The S&P 500 has not followed the traditiona...
NVIDIA leads the Magnificent 7 in March with a 1.7% gain through Friday, while Apple and Tesla retreat as investors r...
The FMC stock story has been rough, but a measured, scenario-driven approach can illuminate where the year ahead migh...